However, a clear trend of increased plasma TG, as well as ALT/AST activity after 24 weeks of GKA treatment, 13 suggests its potential risk on liver function, and liver function status should be considered for GKA prescription.
← all excerpts
Glucokinase activator improves glucose tolerance and induces hepatic lipid accumulation in mice with diet-induced obesity.
1
—
—